United States – Danish drugmaker Ascendis Pharma said in a statement that the US Food & Drugs Administration had green-lighted its therapy for adult patients with hormone disorders, and its shares rose by over 10 percent in the premarket trade, ...
United States – Danish drugmaker Ascendis Pharma said in a statement that the US Food & Drugs Administration had green-lighted its therapy for adult patients with hormone disorders, and its shares rose by over 10 percent in the premarket trade, ...
Join our subscribers list to get the latest news, updates and special offers delivered directly in your inbox.